PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Manulife Financial Corp (MFC-PM.TO)
23.680.18 (-0.75%)
23.68 - 23.68
20.75 - 25.07
1.4K / 5.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
120.45%
Revenue growth exceeding 1.5x Insurance - Life median of 1.73%. Joel Greenblatt would verify if operating margins keep pace with this top-line surge.
120.45%
Gross profit growth exceeding 1.5x Insurance - Life median of 2.63%. Joel Greenblatt would check if cost advantages or brand equity drive this surge.
-39.62%
Negative EBIT growth while Insurance - Life median is -9.39%. Seth Klarman would check if external or internal factors caused the decline.
-39.62%
Negative operating income growth while Insurance - Life median is -10.49%. Seth Klarman would check if structural or cyclical issues are at play.
-41.12%
Negative net income growth while Insurance - Life median is -6.27%. Seth Klarman would investigate factors dragging net income down.
-41.10%
Negative EPS growth while Insurance - Life median is 0.00%. Seth Klarman would explore whether share dilution or profit declines are to blame.
-41.12%
Negative diluted EPS growth while Insurance - Life median is 0.00%. Seth Klarman would look for the cause: weakened profitability or heavier share issuance.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-1.67%
Negative OCF growth while Insurance - Life median is -15.97%. Seth Klarman would ask if accounting or macro issues hamper the firm specifically.
-1.67%
Negative FCF growth while Insurance - Life median is -15.92%. Seth Klarman would see if others in the industry are still generating positive expansions in free cash.
231.90%
10Y revenue/share CAGR exceeding 1.5x Insurance - Life median of 33.14%. Joel Greenblatt would verify if a unique moat or brand fosters outperformance over a decade.
73.85%
5Y revenue/share growth exceeding 1.5x Insurance - Life median of 20.49%. Joel Greenblatt would see if the company’s moat drives rapid mid-term expansion.
94.41%
3Y revenue/share growth exceeding 1.5x Insurance - Life median of 16.09%. Joel Greenblatt might see a short-term competitive advantage at play.
1142.42%
OCF/share CAGR exceeding 1.5x Insurance - Life median of 48.51% over 10 years. Joel Greenblatt would verify if a unique competitive moat underlies these cash flows.
-34.84%
Negative 5Y OCF/share CAGR while Insurance - Life median is 12.53%. Seth Klarman might see a firm-specific issue if peers still expand cash flow.
-22.96%
Negative 3Y OCF/share CAGR while Insurance - Life median is 0.00%. Seth Klarman would check whether it’s cyclical or a firm-specific problem.
85.42%
Net income/share CAGR exceeding 1.5x Insurance - Life median of 50.14% over a decade. Joel Greenblatt might see a standout compounder of earnings.
174.16%
5Y net income/share CAGR > 1.5x Insurance - Life median of 72.14%. Joel Greenblatt might see superior mid-term capital allocation or product strength.
-19.59%
Negative 3Y CAGR while Insurance - Life median is 36.78%. Seth Klarman might see a pressing concern if the rest of the sector is stable or growing.
216.02%
Equity/share CAGR exceeding 1.5x Insurance - Life median of 23.34% over 10 years. Joel Greenblatt would see if a high ROE underlies this compounding advantage.
15.72%
5Y equity/share CAGR 50-75% of Insurance - Life median. Guy Spier sees subpar net worth creation vs. competitors.
24.42%
3Y equity/share CAGR 1.25-1.5x Insurance - Life median. Mohnish Pabrai credits disciplined capital allocation for short-term outperformance.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
12.81%
AR growth of 12.81% while Insurance - Life median is zero. Walter Schloss checks if the difference points to new credit strategy or stronger sales push.
No Data
No Data available this quarter, please select a different quarter.
4.92%
Asset growth exceeding 1.5x Insurance - Life median of 2.31%. Joel Greenblatt confirms strong expansions matched by adequate returns on those assets.
7.42%
BV/share growth exceeding 1.5x Insurance - Life median. Joel Greenblatt checks if consistent ROE or undervalued buybacks fuel this advantage.
6.43%
Debt growth of 6.43% while Insurance - Life median is zero. Walter Schloss might see a modest difference that matters if interest coverage is tight.
No Data
No Data available this quarter, please select a different quarter.
-10.44%
SG&A decline while Insurance - Life grows. Seth Klarman sees potential cost advantage or a risk if it hurts future growth.